COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 1503: Articles 15021-15030  | Next

Coadministration of AYUSH 64 as an adjunct to Standard of Care in mild and moderate COVID-19: A randomised, controlled, multicentric clinical trial
Chopra, A., Tillu, G., Chaudhary, K., Reddy, G., Srivastava, A., Lakdawala, M., Gode, D., Reddy, H., Tamboli, S., Saluja, M., Sarmukkaddam, S., Gundeti, M., Raut, A., Rao, B., Yadav, B., Srikanth, N., Patwardhan, B.
10.1101/2021.06.12.21258345 — Posted: 2021-06-17
Ceylon cinnamon and its major compound Cinnamaldehyde can limit overshooting inflammatory signaling and angiogenesis in vitro: implications for COVID-19 treatment
Lucas, K., Ackermann, M., Leifke, A. L., Li, W. W., Poeschl, U., Froehlich-Nowoisky, J.
10.1101/2021.06.16.448642 — Posted: 2021-06-16
Nafamostat-interferon-alpha combination suppresses SARS-CoV-2 infection in vitro and in vivo
Ianevski, A., Yo, R., Lysvand, H., Grodeland, G., Legrand, N., Tenson, T., Bjoras, M., Kainov, D. E.
10.1101/2021.06.16.448653 — Posted: 2021-06-16
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters
Wuertz, K. M., Barkei, E., Chen, W.-h., Martinez, E. J., Naouar, I. E., Jagodzinski, L., Paquin-Proulx, D., Gromowski, G. D., Swafford, I., Ganesh, A., Dong, M., Zeng, X., Thomas, P. V., Sankhala, R. S., Hajduczki, A., Peterson, C. E., Kuklis, C. H., Soman, S., Wieczorek, L., Zemil, M., Anderson, A., Darden, J., Hernandez, H., Grove, H., Dussupt, V., Hack, H., de la Barrera, R. A., Zarling, S. N., Wood, J. F., Froude, J. W., Gagne, M. J., Henry, A. R., Mokhtari, E. B., Mudvari, P., Krebs, S. J., Pekosz, A. S., Currier, J. R., Kar, S., Porto, M., Winn, A., Radzyminski, K., Lewis, M. G., Vasan, S., Suthar, M., Polonis, V., Matyas, G., Boritz, E. A., Douek, D. C., Seder, R., Daye, S., Rao, M., Peel, S., Joyce, M. G., Bolton, D. L., Michael, N. L., Modjarrad, K.
10.1101/2021.06.16.448525 — Posted: 2021-06-16
SARS-CoV-2 envelope-protein corruption of homeostatic signaling mechanisms in mammalian cells
Schulze, T., Hartel, A., Hoeler, S., Hemming, C., Lehn, R., Tandl, D., Greiner, T., Bertl, A., Shepard, K., Moroni, A., Thiel, G., Rauh, O.
10.1101/2021.06.16.448640 — Posted: 2021-06-16
The Spectre of SARS-CoV-2 in the Ambient Urban Natural Water in Ahmedabad and Guwahati: A Tale of Two Cities
Kumar, M., Mazumder, P., Deka, J. P., Srivastava, V., Mahanta, C., Goswami, R., Gupta, S., Joshi, M., Ramanathan, A.
10.1101/2021.06.12.21258829 — Posted: 2021-06-16
SARS-CoV-2 Viral Replication in a High Throughput Human Primary Epithelial Airway Organ Model
Fisher, C. R., Medie, F. M., Luu, R. J., Gaibler, R., Miller, C. R., Mulhern, T. J., Vijayakumar, V., Marr, E., Alladina, J., Medoff, B., Borenstein, J. T., Gard, A. L.
10.1101/2021.06.15.448611 — Posted: 2021-06-16
Evaluation of saliva molecular point of care for detection of SARS-CoV-2 in ambulatory care
Le Goff, J., Kerneis, S., Elie, C., Mercier Delarue, S., Gastli, N., Choupeaux, L., Fourgeaud, J., Alby, M.-L., Quentin, P., Pavie, J., Brazille, P., Nere, M.-L., Gabassi, A., Minier, M., Leroy, C., Parfait, B., Treluyer, J.-M., Delaugerre, C.
10.1101/2021.06.12.21258811 — Posted: 2021-06-16
Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study
Misra, P., WHO Unity Seroprevalence study team of AIIMS
10.1101/2021.06.15.21258880 — Posted: 2021-06-16
Relative perceived importance of different settings for SARS-CoV2 acquisition in England and Wales: Analysis of the Virus Watch Community Cohort
Beale, S., Byrne, T. E., Fragaszy, E. B., Kovar, J., Nguyen, V. G., Aryee, A., Fong, W. L. E., Geismar, C. R., Patel, P., Shrotri, M., Patni, N., Braithwaite, I., Navaratnam, A. M. D., Aldridge, R. W., Hayward, A. C.
10.1101/2021.06.11.21258730 — Posted: 2021-06-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).